Corteva Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Corteva wird ein jährliches Gewinn- und Umsatzwachstum von 26.2% bzw. 2.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 29.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 10% betragen.
Wichtige Informationen
26.2%
Wachstumsrate der Gewinne
29.2%
EPS-Wachstumsrate
| Chemicals Gewinnwachstum | 16.8% |
| Wachstumsrate der Einnahmen | 2.9% |
| Zukünftige Eigenkapitalrendite | 10.0% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 20 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Corteva Q3: Lower Commodity And Raw Material Costs Ahead, Potential Margin Expansion
Nov 10Market Participants Recognise Corteva, Inc.'s (NYSE:CTVA) Earnings
Nov 08
Corteva (NYSE:CTVA) Might Have The Makings Of A Multi-Bagger
Sep 23Corteva Offers A Pair Of Preferred Shares To Consider
Sep 16Estimating The Intrinsic Value Of Corteva, Inc. (NYSE:CTVA)
Sep 08Corteva Sows Growth, But Harvests Mixed Results In Q2
Sep 05Does Corteva (NYSE:CTVA) Have A Healthy Balance Sheet?
Aug 23Corteva's (NYSE:CTVA) Conservative Accounting Might Explain Soft Earnings
Aug 08Corteva (NYSE:CTVA) Is Increasing Its Dividend To $0.17
Aug 05Getting In Cheap On Corteva, Inc. (NYSE:CTVA) Might Be Difficult
Jul 31Corteva: Bearish Trend Is On With Declining Trading Volume
Jun 18Is Corteva, Inc. (NYSE:CTVA) Trading At A 48% Discount?
May 27There's Been No Shortage Of Growth Recently For Corteva's (NYSE:CTVA) Returns On Capital
May 11Is Corteva (NYSE:CTVA) Using Too Much Debt?
Apr 23Investors Still Waiting For A Pull Back In Corteva, Inc. (NYSE:CTVA)
Apr 05Corteva's Strategic Ascend Post DowDuPont Split: Bridging Valuation Gaps
Apr 02Added Corteva To Our Model Portfolio (Technical Analysis)
Mar 06Some Investors May Be Willing To Look Past Corteva's (NYSE:CTVA) Soft Earnings
Feb 07Corteva, Inc. (NYSE:CTVA) Shares Could Be 45% Below Their Intrinsic Value Estimate
Feb 05Corteva Q4: Strong Positive Tone With Crop Protection Normalization (Upgrade)
Feb 02We Think Corteva (NYSE:CTVA) Can Stay On Top Of Its Debt
Jan 21Corteva's (NYSE:CTVA) Returns On Capital Are Heading Higher
Jan 03Market Participants Recognise Corteva, Inc.'s (NYSE:CTVA) Earnings
Dec 19Corteva: Better Inventory Management For Better Profits
Nov 30Corteva: Weak Brazil Market, Inventory Destocking Challenges; Cost-Cutting Improves Margins
Nov 12Investors Will Want Corteva's (NYSE:CTVA) Growth In ROCE To Persist
Oct 03Corteva: A Leader In The Industry Still Expanding
Sep 24Is Corteva (NYSE:CTVA) Using Too Much Debt?
Sep 18Corteva, Inc.: As Bullish As Ever On This Quality Company
Sep 07Is There Now An Opportunity In Corteva, Inc. (NYSE:CTVA)?
Sep 05Corteva: Near-Term Headwinds, And Long-Term Growth Potential
Aug 14There's Been No Shortage Of Growth Recently For Corteva's (NYSE:CTVA) Returns On Capital
Jun 27Calculating The Intrinsic Value Of Corteva, Inc. (NYSE:CTVA)
Jun 14Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 17,971 | 1,970 | 1,906 | 2,506 | 14 |
| 12/31/2025 | 17,380 | 1,723 | 1,932 | 2,557 | 18 |
| 12/31/2024 | 16,982 | 1,195 | 1,680 | 2,296 | 18 |
| 9/30/2024 | 16,637 | 670 | 1,746 | 2,345 | N/A |
| 6/30/2024 | 16,901 | 874 | 1,503 | 2,110 | N/A |
| 3/31/2024 | 16,834 | 698 | 1,879 | 2,471 | N/A |
| 12/31/2023 | 17,226 | 929 | 1,174 | 1,769 | N/A |
| 9/30/2023 | 17,344 | 1,119 | -143 | 414 | N/A |
| 6/30/2023 | 17,531 | 1,112 | -543 | -6 | N/A |
| 3/31/2023 | 17,738 | 1,234 | -286 | 291 | N/A |
| 12/31/2022 | 17,455 | 1,205 | 267 | 872 | N/A |
| 9/30/2022 | 17,109 | 1,401 | 780 | 1,400 | N/A |
| 6/30/2022 | 16,703 | 1,760 | 1,127 | 1,749 | N/A |
| 3/31/2022 | 16,078 | 1,776 | 1,332 | 1,947 | N/A |
| 12/31/2021 | 15,655 | 1,812 | 2,154 | 2,727 | N/A |
| 9/30/2021 | 15,383 | 1,756 | 1,895 | 2,482 | N/A |
| 6/30/2021 | 14,875 | 1,330 | 1,748 | 2,290 | N/A |
| 3/31/2021 | 14,439 | 1,075 | 1,560 | 2,044 | N/A |
| 12/31/2020 | 14,217 | 736 | 1,589 | 2,064 | N/A |
| 9/30/2020 | 13,993 | 594 | 1,687 | 2,136 | N/A |
| 6/30/2020 | 14,041 | 470 | 758 | 1,289 | N/A |
| 3/31/2020 | 14,406 | 179 | 53 | 681 | N/A |
| 12/31/2019 | 13,846 | -288 | -93 | 1,070 | N/A |
| 9/30/2019 | 13,678 | -1,322 | -536 | 960 | N/A |
| 6/30/2019 | 13,714 | -6,453 | -682 | 985 | N/A |
| 3/31/2019 | 12,921 | -6,965 | -2,093 | -263 | N/A |
| 12/31/2018 | 14,287 | -6,813 | -1,018 | 483 | N/A |
| 9/30/2018 | 14,299 | -3,538 | N/A | N/A | N/A |
| 6/30/2018 | 14,220 | 1,261 | N/A | N/A | N/A |
| 3/31/2018 | 14,230 | 1,898 | N/A | N/A | N/A |
| 12/31/2017 | 10,684 | 2,081 | N/A | -275 | N/A |
| 12/31/2016 | 14,041 | 503 | N/A | N/A | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CTVADas prognostizierte Gewinnwachstum (26.2% pro Jahr) liegt über der Sparquote (2.6%).
Ertrag vs. Markt: CTVADie Erträge des Unternehmens (26.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (15.4% pro Jahr).
Hohe Wachstumserträge: CTVAEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: CTVADie Einnahmen des Unternehmens (2.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (9% pro Jahr).
Hohe Wachstumseinnahmen: CTVADie Einnahmen des Unternehmens (2.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: CTVADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (10%).